Gpi announces that it signed new international contracts worth more than EUR 5 million in the second quarter of 2023. Its flagship technology products are winning over international customers, from the HIS software for triage in Austria to the T1 monitor, the sensor for telemedicine at Umana Medical in China, to robots for pharmacy automation and transfusion software.
Noteworthy a Riedl Phasys automation contract in China for over EUR 1.4 mln and a new donor transfusion centre in Texas.
Live Video Webcast Thursday, October 3, 2024 – 11:00 CET
Revenues +27%, EBITDA +76%. Proposed dividend € 0,35 p.s.
Rossi: We are focusing on the synergy between Gpi companies. Stofella: We are stepping up with new roles